Molina Healthcare (NYSE:MOH) Price Target Cut to $375.00 by Analysts at Wells Fargo & Company

Molina Healthcare (NYSE:MOH) had its price objective cut by Wells Fargo & Company from $410.00 to $375.00 in a research note published on Monday morning, Benzinga reports. They currently have an equal weight rating on the stock.

Other equities research analysts have also recently issued research reports about the stock. Barclays lowered their target price on shares of Molina Healthcare from $437.00 to $430.00 and set an equal weight rating on the stock in a research note on Thursday, April 25th. Truist Financial upped their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a buy rating in a research note on Tuesday, February 20th. Stephens reissued an equal weight rating and issued a $390.00 target price on shares of Molina Healthcare in a research note on Thursday, April 25th. StockNews.com lowered Molina Healthcare from a strong-buy rating to a buy rating in a research report on Thursday, February 8th. Finally, Bank of America downgraded Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price objective on the stock. in a research report on Thursday, March 28th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of Hold and a consensus target price of $397.20.

Molina Healthcare Stock Performance

MOH opened at $343.99 on Monday. The company has a market cap of $20.16 billion, a price-to-earnings ratio of 18.66, a PEG ratio of 0.96 and a beta of 0.47. The firm’s fifty day simple moving average is $389.18 and its two-hundred day simple moving average is $372.38. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. Molina Healthcare has a 52-week low of $266.35 and a 52-week high of $423.92.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, topping the consensus estimate of $5.46 by $0.27. The company had revenue of $9.93 billion during the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. Molina Healthcare’s quarterly revenue was up 21.9% on a year-over-year basis. During the same period in the previous year, the business earned $5.81 EPS. Equities analysts anticipate that Molina Healthcare will post 23.62 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of Molina Healthcare stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the sale, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the transaction, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Mark Lowell Keim sold 15,000 shares of Molina Healthcare stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now directly owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 16,711 shares of company stock worth $6,472,517. Company insiders own 1.11% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Annis Gardner Whiting Capital Advisors LLC acquired a new stake in Molina Healthcare during the 3rd quarter worth approximately $30,000. McIlrath & Eck LLC acquired a new stake in shares of Molina Healthcare in the fourth quarter valued at $34,000. VisionPoint Advisory Group LLC boosted its holdings in Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock valued at $36,000 after purchasing an additional 57 shares during the period. Principal Securities Inc. acquired a new position in Molina Healthcare during the 4th quarter worth $42,000. Finally, Friedenthal Financial purchased a new stake in Molina Healthcare during the 4th quarter worth about $43,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.